Opportunistic Infections Citation List:
October 15 - October 28, 2010
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents. Guan, Z., X. Chai, S. Yu, H. Hu, Y. Jiang, Q. Meng, and Q. Wu. Chemical Biology & Drug Design, 2010. [Epub ahead of print]; PMID[20973917].
[Pubmed]. OI_1015-102810.
(includes Mycobacterium spp., Drug Resistant, MAC, MDR)
2.Effect of exogenous cardiolipin on the growth and viability of Mycobacterium tuberculosis H37Rv in vitro. Andreevskaya, S.N., T.G. Smirnova, Y.A. Zhogina, D.I. Smirnova, Y.L. Mikulovich, G.M. Sorokoumova, L.N. Chernousova, A.A. Selishcheva, and V.I. Shvets. Doklady Biological Sciences, 2010. 434(1): p. 371-374; PMID[20963667].
[Pubmed]. OI_1015-102810.
3.Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols. Bisht, S.S., N. Dwivedi, V. Chaturvedi, N. Anand, M. Misra, R. Sharma, B. Kumar, R. Dwivedi, S. Singh, S.K. Sinha, V. Gupta, P.R. Mishra, A.K. Dwivedi, and R.P. Tripathi. European Journal of Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[20970222].
[Pubmed]. OI_1015-102810
4.Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring. Khoje, A.D., A. Kulendrn, C. Charnock, B. Wan, S. Franzblau, and L.L. Gundersen. Bioorganic & Medicinal Chemistry, 2010. 18(20): p. 7274-7282; PMID[20833056].
[Pubmed]. OI_1015-102810
5.Hapalindole-related alkaloids from the cultured cyanobacterium Fischerella ambigua. Mo, S., A. Krunic, B.D. Santarsiero, S.G. Franzblau, and J. Orjala. Phytochemistry, 2010. [Epub ahead of print];
PMID[20965528].
[Pubmed]. OI_1015-102810.
Citations from the ISI Web of Knowledge Listings for O.I.
6.Synthesis and Antitubercular Evaluation of New Bis-1,2,3-Triazoles Derived from D-Mannitol. Ferreira, M.D., M.V.N. de Souza, S. Wardell, J.L. Wardell, T.R.A. Vasconcelos, V.F. Ferreira, and M.C.S. Lourenco. Journal of Carbohydrate Chemistry, 2010. 29(6): p. 265-274; ISI[000282582600001].
[WOS]. OI_1015-102810.
7.Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: Novel antibacterial agents against Mycobacterium tuberculosis. Li, X.K., N.N. Liu, H.N. Zhang, S.E. Knudson, R.A. Slayden, and P.J. Tonge. Bioorganic & Medicinal Chemistry Letters, 2010. 20(21): p. 6306-6309; ISI[000282677900032].
[WOS]. OI_1015-102810.
8.Design, synthesis, and biological evaluation of 4-(5-nitrofuran-2-yl) prop-2-en-1-one derivatives as potent antitubercular agents. Tawari, N.R., R. Bairwa, M.K. Ray, M.G.R. Rajan, and M.S. Degani. Bioorganic & Medicinal Chemistry Letters, 2010. 20(21): p. 6175-6178; ISI[000282677900002].
[WOS]. OI_1015-102810.
9.Promising Antimicrobial Agents: Synthetic Approaches to Novel Tricyclic and Tetracyclic Pyrimidinones with Antimicrobial Properties. Gaber, H.M., M.C. Bagley, S.M. Sherif, and U.M. Abdul-Raouf. Journal of Heterocyclic Chemistry, 2010. 47(5): p. 1162-1170; ISI[000282489200026].
[WOS]. OI_1015-102810.